These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 20589670

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.
    Genzel Y, Fischer M, Reichl U.
    Vaccine; 2006 Apr 12; 24(16):3261-72. PubMed ID: 16472544
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media.
    Genzel Y, Olmer RM, Schäfer B, Reichl U.
    Vaccine; 2006 Aug 28; 24(35-36):6074-87. PubMed ID: 16781022
    [Abstract] [Full Text] [Related]

  • 5. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines.
    Hu AY, Weng TC, Tseng YF, Chen YS, Wu CH, Hsiao S, Chou AH, Chao HJ, Gu A, Wu SC, Chong P, Lee MS.
    Vaccine; 2008 Oct 23; 26(45):5736-40. PubMed ID: 18761387
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: in vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells.
    Hussain AI, Cordeiro M, Sevilla E, Liu J.
    Vaccine; 2010 May 14; 28(22):3848-55. PubMed ID: 20307595
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries.
    Rudenko L, van den Bosch H, Kiseleva I, Mironov A, Naikhin A, Larionova N, Bushmenkov D.
    Vaccine; 2011 Jul 01; 29 Suppl 1():A40-4. PubMed ID: 21684428
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers.
    Heldens J, Hulskotte E, Voeten T, Breedveld B, Verweij P, van Duijnhoven W, Rudenko L, van Damme P, van den Bosch H.
    Vaccine; 2014 Sep 03; 32(39):5118-24. PubMed ID: 24858566
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production-Flow cytometry and mathematical modeling.
    Schulze-Horsel J, Schulze M, Agalaridis G, Genzel Y, Reichl U.
    Vaccine; 2009 May 05; 27(20):2712-22. PubMed ID: 19428884
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Generation of a High-Growth Influenza Vaccine Strain in MDCK Cells for Vaccine Preparedness.
    Kim EH, Kwon HI, Park SJ, Kim YI, Si YJ, Lee IW, Kim SM, Kim SI, Ahn DH, Choi YK.
    J Microbiol Biotechnol; 2018 Jun 28; 28(6):997-1006. PubMed ID: 29642288
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.